Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation.
Lee KH, Park HW, Lee N, Hyun DY, Won J, Oh SS, Park HJ, Kim Y, Cho JY, Kim MC, Sim DS, Yoon HJ, Yoon NS, Kim KH, Hong YJ, Kim JH, Ahn Y, Jeong MH, Park JC, Cho JG.
Lee KH, et al. Among authors: kim mc, kim y, kim kh, kim jh.
Europace. 2017 Dec 1;19(suppl_4):iv1-iv9. doi: 10.1093/europace/eux247.
Europace. 2017.
PMID: 29220421